Evidence map›Paper›PMID 41365927›Full record

ArticleNature communications2025

Cancer-associated USP28 missense mutations disrupt 53BP1 interaction and p53 stabilization.

Hazrat Belal, Esther Feng Ying Ng, Midori Ohta, Franz Meitinger

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Ubiquitin System-Driven Proteostasis in DNA Damage Response.International journal of molecular sciences · 2026
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hazrat BelalOkinawa Institute of Science and Technology Graduate University, Okinawa, Japan.ORCID http://orcid.org/0000-0002-2192-8727
Esther Feng Ying NgOkinawa Institute of Science and Technology Graduate University, Okinawa, Japan.ORCID http://orcid.org/0009-0007-1073-9465
Midori OhtaOkinawa Institute of Science and Technology Graduate University, Okinawa, Japan.ORCID http://orcid.org/0000-0001-8189-6846
Franz MeitingerOkinawa Institute of Science and Technology Graduate University, Okinawa, Japan. franz.meitinger@oist.jp.ORCID http://orcid.org/0000-0002-8635-9078

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 23K05773MEXT | Japan Society for the Promotion of Science (JSPS) 24K09461MEXT | Japan Society for the Promotion of Science (JSPS) 25H02402
6 · The paper itself

Abstract

Cellular stress response pathways are essential for genome stability and are frequently dysregulated in cancer. Following mitotic stress, the ubiquitin-specific protease 28 (USP28) and the p53-binding protein 1 (53BP1) form a stable, heritable complex to stabilize the tumor suppressor p53, triggering cell cycle arrest or apoptosis. Here, we demonstrate that USP28 stabilizes p53 through deubiquitination. We further show that USP28 is required not only for an efficient stress response but also for maintaining basal p53 levels in some cancer cells. Loss of functional USP28 allows cells to evade mitotic stress and DNA damage responses in a manner that is specific to cell type and cancer context. We identify a prevalent, shorter USP28 isoform critical for p53 stabilization. Its C-terminal domain mediates PLK1-dependent binding to 53BP1, a dimerization-driven interaction necessary for mitotic stress memory, p53 stabilization, and cell cycle arrest. Cancer-associated missense mutations in this domain disrupt 53BP1 binding, impair nuclear localization, and destabilize USP28, compromising p53 stabilization. Notably, mutations in the 53BP1-binding domain occur more frequently in tumors than those in the catalytic domain, suggesting a potential role in cancer progression and implications for therapeutic strategies.

Indexed as

Mutation, MissenseNeoplasmsTumor Suppressor p53-Binding Protein 1Tumor Suppressor Protein p53Ubiquitin ThiolesteraseCell Cycle CheckpointsCell Cycle ProteinsCell Line, TumorDNA DamageHEK293 CellsHumansProtein BindingProtein StabilityUbiquitinationCell Cycle ProteinsTP53BP1 protein, humanTP53 protein, humanTumor Suppressor p53-Binding Protein 1Tumor Suppressor Protein p53Ubiquitin ThiolesteraseUSP28 protein, human

Identifiers

PMID41365927
PMCPMC12689633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.